Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Non-Current Deferred Tax Liability (2019 - 2022)

Phibro Animal Health (PAHC) has 3 years of Non-Current Deferred Tax Liability data on record, last reported at $8.1 million in Q4 2021.

  • For Q4 2021, Non-Current Deferred Tax Liability fell 33.09% year-over-year to $8.1 million; the TTM value through Dec 2021 reached $8.1 million, down 33.09%, while the annual FY2021 figure was $6.6 million, N/A changed from the prior year.
  • Non-Current Deferred Tax Liability reached $8.1 million in Q4 2021 per PAHC's latest filing, up from $6.6 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $12.4 million in Q1 2021 and bottomed at $6.6 million in Q2 2021.
  • Average Non-Current Deferred Tax Liability over 3 years is $9.7 million, with a median of $9.5 million recorded in 2019.
  • Peak YoY movement for Non-Current Deferred Tax Liability: rose 26.6% in 2020, then tumbled 33.09% in 2021.
  • A 3-year view of Non-Current Deferred Tax Liability shows it stood at $9.5 million in 2019, then rose by 26.6% to $12.1 million in 2020, then crashed by 33.09% to $8.1 million in 2021.
  • Per Business Quant database, its latest 3 readings for Non-Current Deferred Tax Liability were $8.1 million in Q4 2021, $6.6 million in Q2 2021, and $12.4 million in Q1 2021.